Absorption | Bioavailability is 100% (intravenous). |
Volume of distribution |
|
Protein binding | 54% |
Metabolism | Liver via hydroxylation and aromatization of the 3-methyltetrahydroquinoline ring. Age and gender do not substantially affect the pharmacodynamic or pharmacokinetic profile of argatroban. |
Route of elimination | Argatroban is excreted primarily in the feces (65%), presumably through biliary secretion; 22% is eliminated via urine. |
Half life | 39 and 51 minutes |
Clearance |
|
Toxicity | Excessive bleeding |
Affected organisms |
|
Argatroban
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment